Industries that produce health-harming products have a consistent track record of influencing, weakening, delaying and preventing the development and implementation of cost-effective policies for NCD prevention to protect their profits. The HLM4 is facing the same challenges. Industry actors are already approaching policymakers in New York and capitals, questioning well-established evidence and propagating common myths and misconceptions to persuade governments against committing to bold action on NCDs. Check out our myth buster to help you address industry interference.